

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Adenosine Receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZM241385 | ✔ | 99%+ | |||||||||||||||||
| Istradefylline |
+++
Adenosine A2A receptor, Ki: 2.2 nM |
98% | |||||||||||||||||
| Reversine |
+
human A3 adenosine receptor, Ki: 0.66 μM |
98% | |||||||||||||||||
| SCH58261 |
++++
rat A2a, Ki: 2.3 nM bovine A2a, Ki: 2.0 nM |
99%+ | |||||||||||||||||
| A2A receptor antagonist 1 |
++
A2AR, Ki: 4 nM A1R, Ki: 264 nM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | GS-6201, also known as CVT-6883, acts as a selective antagonist for the adenosine A2B receptor. It exhibits a strong affinity and specificity towards human adenosine A2B receptors, with an inhibition constant Ki value of 22 nM[1]. |
| Animal study | GS-6201 diminishes the activity of caspase-1 in the heart and mitigates the cardiac changes following an acute myocardial infarction (AMI) in mice. When administered at a dosage of 4 mg/kg intraperitoneally every 12 hours for two weeks, GS-6201 notably lowers the plasma levels of IL-6, TNF-α, E-selectin, ICAM-1, and VCAM. Additionally, this treatment significantly reduces the enlargement and dysfunction of both the left and right ventricles after 7 days, with these effects persisting at both 14 and 28 days[2]. Treatment with GS-6201, administered orally at a dose of 2 mg/kg, results in a Cmax of 1110 ng/mL, a dAUC of 6500 ng·h/mL, and a half-life (t1/2) of 4.25 hours[1]. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.24mL 0.45mL 0.22mL |
11.20mL 2.24mL 1.12mL |
22.40mL 4.48mL 2.24mL |
|
| CAS号 | 752222-83-6 |
| 分子式 | C21H21F3N6O2 |
| 分子量 | 446.43 |
| SMILES Code | O=C(N(CC)C2=C1NC(C3=CN(CC4=CC=CC(C(F)(F)F)=C4)N=C3)=N2)N(CCC)C1=O |
| MDL No. | MFCD11042420 |
| 别名 | CVT-6883 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(235.2 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1